Enforcement record
License Revocation disclosure naming ロシュ
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
License Revocation
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
17 August 2022
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Apr 28, 2026, 09:01 AM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Public documents and saved materials
View the original publications, see what was preserved, or download each file below.
Loading materials…
Action summary
- Company
- ロシュJapanese onlyOriginal: ロシュ
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- License Revocation許可取消し
- Action date
- 17 August 2022
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品・医療機器
Violation
Rapidly approved OTC status for COVID-19 antigen test kits and began internet sales.
Show original Japanese text
新型コロナウイルス抗原検査キットのOTC化を迅速に承認し、インターネット販売を開始。
Compliance context
HighA regulator revoked an authorization or license required for the covered activity.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Verify the affected business line and whether the company can legally perform the contemplated service.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.